Decreased bone mineral density during GnRH analog therapy and polymorphism of estrogen receptor gene in precocious puberty.
Nakayama
Y
Y
Department of Pediatrics, Juntendo University School of Medicine, Tokyo, Japan.
Tadokoro
R
R
Arisaka
O
O
Tokita
A
A
Yamashiro
Y
Y
D015519:Bone Density / Q000187:drug effects*; D002064:Buserelin / Q000494:pharmacology*; D002648:Child; D002675:Child, Preschool; D005260:Female; D007987:Gonadotropin-Releasing Hormone / Q000009:adverse effects* / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006801:Humans; D016729:Leuprolide / Q000494:pharmacology*; D016133:Polymerase Chain Reaction; D012150:Polymorphism, Restriction Fragment Length; D011629:Puberty, Precocious / Q000188:drug therapy* / Q000235:genetics / Q000378:metabolism; D011960:Receptors, Estrogen / Q000235:genetics*
D011960:Receptors, Estrogen; D007987:Gonadotropin-Releasing Hormone; C083781:LHRH, Ala(6)-Gly(10)-ethylamide-; D016729:Leuprolide; D002064:Buserelin